Pre-Market Registration Fees Beckon In NZ For Medtech
This article was originally published in Clinica
Medtech companies seeking to market their products in New Zealand might have to start paying a fee to do so, following proposals by the government to introduce the country's first ever pre-market registration requirements for medical devices.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
GenSight Biologics believes Lumevoq could become the first curative treatment for Leber hereditary optic neuropathy.